Literature DB >> 20930144

ATF3, an adaptive-response gene, enhances TGF{beta} signaling and cancer-initiating cell features in breast cancer cells.

Xin Yin1, Christopher C Wolford, Yi-Seok Chang, Stephen J McConoughey, Stephen A Ramsey, Alan Aderem, Tsonwin Hai.   

Abstract

The activating transcription factor 3 (ATF3) gene is induced by a variety of signals, including many of those encountered by cancer cells. We present evidence that ATF3 is induced by TGFβ in the MCF10CA1a breast cancer cells and plays an integral role for TGFβ to upregulate its target genes snail, slug and twist, and to enhance cell motility. Furthermore, ATF3 upregulates the expression of the TGFb gene itself, forming a positive-feedback loop for TGFβ signaling. Functionally, ectopic expression of ATF3 leads to morphological changes and alterations of markers consistent with epithelial-to-mesenchymal transition (EMT). It also leads to features associated with breast-cancer-initiating cells: increased CD24(low)-CD44(high) population of cells, mammosphere formation and tumorigenesis. Conversely, knockdown of ATF3 reduces EMT, CD24(low)-CD44(high) cells and mammosphere formation. Importantly, knocking down twist, a downstream target, reduces the ability of ATF3 to enhance mammosphere formation, indicating the functional significance of twist in ATF3 action. To our knowledge, this is the first report demonstrating the ability of ATF3 to enhance breast cancer-initiating cell features and to feedback on TGFβ. Because ATF3 is an adaptive-response gene and is induced by various stromal signals, these findings have significant implications for how the tumor microenvironment might affect cancer development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20930144      PMCID: PMC2951469          DOI: 10.1242/jcs.064915

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  49 in total

Review 1.  ATF3 and stress responses.

Authors:  T Hai; C D Wolfgang; D K Marsee; A E Allen; U Sivaprasad
Journal:  Gene Expr       Date:  1999

Review 2.  TGF-beta latency: biological significance and mechanisms of activation.

Authors:  P E Gleizes; J S Munger; I Nunes; J G Harpel; R Mazzieri; I Noguera; D B Rifkin
Journal:  Stem Cells       Date:  1997       Impact factor: 6.277

3.  The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer.

Authors:  Sucharita Bandyopadhyay; Ying Wang; Rui Zhan; Sudha K Pai; Misako Watabe; Megumi Iiizumi; Eiji Furuta; Sonia Mohinta; Wen Liu; Shigeru Hirota; Sadahiro Hosobe; Taisei Tsukada; Kunio Miura; Yukio Takano; Ken Saito; Therese Commes; David Piquemal; Tsonwin Hai; Kounosuke Watabe
Journal:  Cancer Res       Date:  2006-12-15       Impact factor: 12.701

4.  An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct.

Authors:  M Abe; J G Harpel; C N Metz; I Nunes; D J Loskutoff; D B Rifkin
Journal:  Anal Biochem       Date:  1994-02-01       Impact factor: 3.365

5.  The anti-invasive activity of cyclooxygenase inhibitors is regulated by the transcription factor ATF3 (activating transcription factor 3).

Authors:  Frank G Bottone; Yuseok Moon; Jong Sik Kim; Brenda Alston-Mills; Minako Ishibashi; Thomas E Eling
Journal:  Mol Cancer Ther       Date:  2005-05       Impact factor: 6.261

Review 6.  Non-Smad TGF-beta signals.

Authors:  Aristidis Moustakas; Carl-Henrik Heldin
Journal:  J Cell Sci       Date:  2005-08-15       Impact factor: 5.285

Review 7.  The cancer stem cell hypothesis: a work in progress.

Authors:  Brenton Thomas Tan; Christopher Yongchul Park; Laurie Elizabeth Ailles; Irving L Weissman
Journal:  Lab Invest       Date:  2006-10-30       Impact factor: 5.662

8.  Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis.

Authors:  Dan Lu; Curt D Wolfgang; Tsonwin Hai
Journal:  J Biol Chem       Date:  2006-02-09       Impact factor: 5.157

Review 9.  Comparative genomic hybridization and chromosomal instability in solid tumours.

Authors:  P H Rooney; G I Murray; D A Stevenson; N E Haites; J Cassidy; H L McLeod
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

10.  Expression of the beta 6 integrin subunit in development, neoplasia and tissue repair suggests a role in epithelial remodeling.

Authors:  J M Breuss; J Gallo; H M DeLisser; I V Klimanskaya; H G Folkesson; J F Pittet; S L Nishimura; K Aldape; D V Landers; W Carpenter
Journal:  J Cell Sci       Date:  1995-06       Impact factor: 5.285

View more
  66 in total

Review 1.  The role of cytokines in breast cancer development and progression.

Authors:  Marcela Esquivel-Velázquez; Pedro Ostoa-Saloma; Margarita Isabel Palacios-Arreola; Karen E Nava-Castro; Julieta Ivonne Castro; Jorge Morales-Montor
Journal:  J Interferon Cytokine Res       Date:  2014-07-28       Impact factor: 2.607

2.  Adenylate kinase 4 promotes bladder cancer cell proliferation and invasion.

Authors:  Feng Xin; Dong-Wei Yao; Li Fan; Jiu-Hua Liu; Xiao-Dong Liu
Journal:  Clin Exp Med       Date:  2019-08-28       Impact factor: 3.984

3.  3,3'-diindolylmethane induces activating transcription factor 3 (ATF3) via ATF4 in human colorectal cancer cells.

Authors:  Seong-Ho Lee; Kyung-Won Min; Xiaobo Zhang; Seung Joon Baek
Journal:  J Nutr Biochem       Date:  2012-07-21       Impact factor: 6.048

4.  Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance.

Authors:  Lev M Kats; Markus Reschke; Riccardo Taulli; Olga Pozdnyakova; Kerri Burgess; Parul Bhargava; Kimberly Straley; Rahul Karnik; Alexander Meissner; Donald Small; Shinsan M Su; Katharine Yen; Jiangwen Zhang; Pier Paolo Pandolfi
Journal:  Cell Stem Cell       Date:  2014-01-16       Impact factor: 24.633

5.  Immunohistochemical detection of activating transcription factor 3, a hub of the cellular adaptive-response network.

Authors:  Tsonwin Hai; Swati Jalgaonkar; Christopher C Wolford; Xin Yin
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

6.  Runx2, a target gene for activating transcription factor-3 in human breast cancer cells.

Authors:  M Gokulnath; N C Partridge; N Selvamurugan
Journal:  Tumour Biol       Date:  2014-11-08

7.  Acquisition of Chemoresistance and Other Malignancy-related Features of Colorectal Cancer Cells Are Incremented by Ribosome-inactivating Stress.

Authors:  Chang-Kyu Oh; Seung Joon Lee; Seong-Hwan Park; Yuseok Moon
Journal:  J Biol Chem       Date:  2016-03-09       Impact factor: 5.157

8.  The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.

Authors:  Saisai Wei; Hongbo Wang; Chunwan Lu; Sarah Malmut; Jianqiao Zhang; Shumei Ren; Guohua Yu; Wei Wang; Dale D Tang; Chunhong Yan
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

9.  High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer.

Authors:  Julia Izrailit; Hal K Berman; Alessandro Datti; Jeffrey L Wrana; Michael Reedijk
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

10.  ATF3 expression in the corpus luteum: possible role in luteal regression.

Authors:  Dagan Mao; Xiaoying Hou; Heather Talbott; Robert Cushman; Andrea Cupp; John S Davis
Journal:  Mol Endocrinol       Date:  2013-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.